Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 2, 2012NeurologyOpen Access

Caffeine for treatment of Parkinson disease

View Full Paper
Ask AI
Bookmark
Share

Authors

RPRonald B. PostumaMontreal Neurological Institute and HospitalALAnthony E. LangUniversité Claude Bernard Lyon 1RMRenato P. MunhozUniversity of Toronto

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Postuma et al. (2012) studied this question.

synapsesocial.com/papers/6a9cbb3f9718b06d6676e359https://doi.org/10.1212/wnl.0b013e318263570d
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial2005 · 266 citations
  2. 2Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease2002 · 272 citations
  3. 3The MOS 36-ltem Short-Form Health Survey (SF-36)1992 · 30,244 citations
  4. 4Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers2007 · 61 citations
  5. 5Adenosine and its receptors2008 · 95 citations